SimCardioTest at the World AI Cannes Festival
From 14 to 16 April, the WORLD AI CANNES FESTIVAL 2022 gathered thousands of professionals and visitors during 3 days through a rich and diversified program, to discover and understand the multiple ways in which artificial intelligence will impact profession, activity and life. SimCardioTest scientists attended this event and presented their work in different ways: […]
SimCardioTest General Assembly and hands-on on V&V
From 23 to 25 March, SimCardioTest organised its first General Assembly. Time was dedicated to share updates on each workpackage and use case advances. Intensive hands-on sessions were also organised to define the different potential applications and questions of interest for each use case, a key aspect in the Verification & Validation process. The first […]
Verification & validation of in-silico models, a european effort
SimCardioTest takes the mature field of cardiac simulations and brings it further through a web-based platform to perform standardised in-silico trials for testing the efficacy and safety of drugs and devices in 3 concrete use cases. The verification and uncertainty quant-ification, to abide by the standards, will allow to quantify discretisation error (in time and […]
Research Positions at UPV
Our Partner Universitat Politècnica de València (UPV) seeks two highly motivated candidates (pre or post-doc) to develop computational multiscale personalized models of the electrical activity of the heart to enable the in silico testing of drug efficacy and safety under healthy and pathological conditions. This 3 year position is in the framework of SimCardioTest. The […]
SimCardiotest workshop on verification & validation of in-silico models
SimCardioTest takes the mature field of cardiac simulations and brings it further through a web-based platform to perform standardised in-silico trials for testing the efficacy and safety of drugs and devices in 3 concrete use cases. The verification and uncertainty quant-ification, to abide by the standards, will allow to quantify discretisation error (in time and […]
SimCardioTest will demonstrate the benefit of in-silico trials, testing three use cases in cardiology.
Our health data can significantly contribute to better disease prevention, early diagnosis in a safe and secure way. SimCardioTest, led by Inria, gathers ten international partners including VPHi, and is funded by the European Commission. The aim of SimCardioTest is to demonstrate the feasibility, efficacy and benefits of in-silico trials for disease. SimCardioTest is developing […]
SimCardioTest First General Assembly
The first General Assembly will be held on 7th to 9th February 2022, at Inria, Sophia-Antipolis, France
What computational sciences can do for your heart
Article on SimCardioTest use cases, published in The Project Respoitory Journal – vol 10 -July 2021. p76-77 published by the European Dissemination Media Agency. By Michèle Barbier, Oscar Camara, Yves Coudière, Beatriz Trenor & Maxime Sermesant.
World Heart Day – Cocktail-conference at Inria
September 29 is World Heart Day. In order to celebrate this special day, a cocktail-conference evening on the digital heart is organised at Inria. During this evening, cardiologists and mathematicians will discuss the impact of digital technologies on the diagnosis and treatment of cardiac pathologies. Programme le coeur numérique 29 Septembre Inria Registration
Registration – WK on standardisation
REGISTRATION OPEN! The registration is open to attend the Workshop on standardisation, October 28-29 October 2021, at Inria, Sophia Antipolis, France. The workshop is only open to SimCardioTest members. It will include plenary talks and hands-on on the three use cases. PhD, post-doc are encouraged to participate and organise a session on their own. Organised […]